Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ovarian Neoplasms

  Free Subscription


15.10.2018

2 BMC Cancer
1 Br J Cancer
1 Eur J Obstet Gynecol Reprod Biol
4 Gynecol Oncol
1 Int J Cancer
7 Int J Gynecol Pathol
2 Int J Oncol
3 Lancet Oncol
3 Obstet Gynecol
3 Oncogene
1 Oncol Rep
1 Oncology
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Cancer

  1. MCGRATH SE, Annels N, Madhuri TK, Tailor A, et al
    Engrailed-2 (EN2) - a novel biomarker in epithelial ovarian cancer.
    BMC Cancer. 2018;18:943.
    PubMed     Text format     Abstract available

  2. BRUNETTE LL, Mhawech-Fauceglia PY, Ji L, Skeate JG, et al
    Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study.
    BMC Cancer. 2018;18:970.
    PubMed     Text format     Abstract available


    Br J Cancer

  3. WANG P, Magdolen V, Seidl C, Dorn J, et al
    Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer.
    Br J Cancer. 2018 Oct 5. pii: 10.1038/s41416-018-0260.
    PubMed     Text format     Abstract available


    Eur J Obstet Gynecol Reprod Biol

  4. LOAEC C, Bats AS, Ngo C, Cornou C, et al
    Dual docking robotic surgical staging for high risk endometrial cancer.
    Eur J Obstet Gynecol Reprod Biol. 2018;225:79-83.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  5. BELUR NAGARAJ A, Joseph P, Kovalenko O, Wang Q, et al
    Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer.
    Gynecol Oncol. 2018 Oct 6. pii: S0090-8258(18)31238.
    PubMed     Text format     Abstract available

  6. NAUMANN RW, Morris JC, Tait DL, Higgins RV, et al
    Patients with BRCA mutations have superior outcomes after intraperitoneal chemotherapy in optimally resected high grade ovarian cancer.
    Gynecol Oncol. 2018 Oct 8. pii: S0090-8258(18)31282.
    PubMed     Text format     Abstract available

  7. ELNAGGAR AC, Hade EM, O'Malley DM, Liang MI, et al
    Time to chemotherapy in ovarian cancer: Compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer Center.
    Gynecol Oncol. 2018 Sep 30. pii: S0090-8258(18)31233.
    PubMed     Text format     Abstract available

  8. WANG J, Dean DC, Hornicek FJ, Shi H, et al
    RNA sequencing (RNA-Seq) and its application in ovarian cancer.
    Gynecol Oncol. 2018 Oct 5. pii: S0090-8258(18)31283.
    PubMed     Text format     Abstract available


    Int J Cancer

  9. FELIX AS, Brasky TM, Cohn DE, Mutch DG, et al
    Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study.
    Int J Cancer. 2017 Oct 24. doi: 10.1002/ijc.31127.
    PubMed     Text format     Abstract available


    Int J Gynecol Pathol

  10. SIMONS M, Ebisch I, de Hullu J, van Ham M, et al
    A Patient With a Low-grade Mucinous Neoplasm Involving the Ovary and Pseudomyxoma Peritonei Originating in an Isolated Intestinal Duplication.
    Int J Gynecol Pathol. 2018;37:338-343.
    PubMed     Text format     Abstract available

  11. BUZA N, Wong S, Hui P
    FOXL2 Mutation Analysis of Ovarian Sex Cord-Stromal Tumors: Genotype-Phenotype Correlation With Diagnostic Considerations.
    Int J Gynecol Pathol. 2018;37:305-315.
    PubMed     Text format     Abstract available

  12. HOLMES M, Robb T
    A Rare Case of Primary Apocrine Adenocarcinoma Arising Within a Mature Cystic Teratoma of the Ovary, Metastatic to a Supraclavicular Lymph Node.
    Int J Gynecol Pathol. 2018;37:344-346.
    PubMed     Text format     Abstract available

  13. SINGH N, Benson JL, Gan C, Anglesio M, et al
    Disease Distribution in Low-stage Tubo-ovarian High-grade Serous Carcinoma (HGSC): Implications for Assigning Primary Site and FIGO Stage.
    Int J Gynecol Pathol. 2018;37:324-330.
    PubMed     Text format     Abstract available

  14. JU B, Wang J, Yang B, Sun L, et al
    Morphologic and Immunohistochemical Study of Clear Cell Carcinoma of the Uterine Endometrium and Cervix in Comparison to Ovarian Clear Cell Carcinoma.
    Int J Gynecol Pathol. 2018;37:388-396.
    PubMed     Text format     Abstract available

  15. STEWART CJR, Crook ML
    Cerebellar Differentiation in Ovarian Teratoma: A Report of 6 Cases.
    Int J Gynecol Pathol. 2018;37:316-323.
    PubMed     Text format     Abstract available

  16. HONG S, Cui J, Li L, Buscema J, et al
    Malignant Female Adnexal Tumor of Probable Wolffian Origin: Case Report and Literature Review.
    Int J Gynecol Pathol. 2018;37:331-337.
    PubMed     Text format     Abstract available


    Int J Oncol

  17. WANG Y, Qiu C, Lu N, Liu Z, et al
    FOXD1 is targeted by miR-30a-5p and miR-200a-5p and suppresses the proliferation of human ovarian carcinoma cells by promoting p21 expression in a p53-independent manner.
    Int J Oncol. 2018 Apr 4. doi: 10.3892/ijo.2018.4359.
    PubMed     Text format     Abstract available

  18. QIU C, Wang Y, Wang X, Zhang Q, et al
    Combination of TP53 and AGR3 to distinguish ovarian high-grade serous carcinoma from low-grade serous carcinoma.
    Int J Oncol. 2018 Apr 4. doi: 10.3892/ijo.2018.4360.
    PubMed     Text format     Abstract available


    Lancet Oncol

  19. MERRITT MA, Tworoger SS
    Common analgesics and ovarian cancer prognosis - Authors' reply.
    Lancet Oncol. 2018;19:e507.
    PubMed     Text format    

  20. FAN G, Xu G, Zhang X
    Common analgesics and ovarian cancer prognosis.
    Lancet Oncol. 2018;19:e506.
    PubMed     Text format    

  21. JIE J, Niu W
    Common analgesics and ovarian cancer prognosis.
    Lancet Oncol. 2018;19:e505.
    PubMed     Text format    


    Obstet Gynecol

  22. VAN NAGELL JR JR, Burgess BT, Miller RW, Baldwin L, et al
    Survival of Women With Type I and II Epithelial Ovarian Cancer Detected by Ultrasound Screening.
    Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002921.
    PubMed     Text format     Abstract available

  23. ROBERTSON SE, Peipert JF
    Ultrasound Screening for Ovarian Cancer: Are We There Yet?
    Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002962.
    PubMed     Text format    

  24. SUH-BURGMANN E, Flanagan T, Osinski T, Alavi M, et al
    Prospective Validation of a Standardized Ultrasonography-Based Ovarian Cancer Risk Assessment System.
    Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002939.
    PubMed     Text format     Abstract available


    Oncogene

  25. CORKERY DP, Clarke LE, Gebremeskel S, Salsman J, et al
    Loss of PRP4K drives anoikis resistance in part by dysregulation of epidermal growth factor receptor endosomal trafficking.
    Oncogene. 2018;37:174-184.
    PubMed     Text format     Abstract available

  26. YAMAGUCHI H, Du Y, Nakai K, Ding M, et al
    EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available

  27. MCLEAN K, Tan L, Bolland DE, Coffman LG, et al
    Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth.
    Oncogene. 2018 Oct 10. pii: 10.1038/s41388-018-0523.
    PubMed     Text format     Abstract available


    Oncol Rep

  28. KAWAI Y, Shibata K, Sakata J, Suzuki S, et al
    KIF20A expression as a prognostic indicator and its possible involvement in the proliferation of ovarian clearcell carcinoma cells.
    Oncol Rep. 2018;40:195-205.
    PubMed     Text format     Abstract available


    Oncology

  29. SEKINE K, Hamaguchi T, Shoji H, Takashima A, et al
    Retrospective Analyses of Systemic Chemotherapy and Cytoreductive Surgery for Patients with Ovarian Metastases from Colorectal Cancer: A Single-Center Experience.
    Oncology. 2018 Jul 20:1-9. doi: 10.1159/000489665.
    PubMed     Text format     Abstract available


    PLoS One

  30. FUJISAWA M, Moh-Moh-Aung A, Zeng Z, Yoshimura T, et al
    Ovarian stromal cells as a source of cancer-associated fibroblasts in human epithelial ovarian cancer: A histopathological study.
    PLoS One. 2018;13:e0205494.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: